Raymond D Baird

Vertex Scores A Big Win With Its Cystic Fibrosis Experiment

• The data is unambiguous and supports the companys expansion in the largest subgroup of cystic fibrosis patients, write Raymond Baird analyst Brian Skorney in his note. We believe the most important takeaway from this new data is the consistent lung function benefit from the combination of a corr
• Date: Apr 19, 2013
• Category: Health
• Source: Google